Literature DB >> 20567854

Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window.

Uwe Querfeld1, Robert H Mak.   

Abstract

Both vitamin D deficiency and vitamin D toxicity are associated with cardiovascular complications in chronic kidney disease (CKD). Clinical and experiment data indicate that the association of vitamin D levels with cardiovascular disease is best illustrated as a biphasic, or U-shaped, curve. Children and adolescents with CKD need vitamin D due to the demands of a growing skeleton, to prevent renal rickets. However, this therapy carries the risk of severe side effects and chronic toxicity. Observational studies show that vitamin D deficiency and toxicity are frequently present in patients with CKD. In view of the importance of cardiovascular complications for the long-term survival of young patients, these findings demand a judicious use of vitamin D preparations. In clinical practice, the therapeutic window is rather small, presenting a therapeutic challenge to avoid both vitamin D deficiency and toxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20567854     DOI: 10.1007/s00467-010-1574-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  174 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

2.  Oral active vitamin D is associated with improved survival in hemodialysis patients.

Authors:  Manuel Naves-Díaz; Daniel Alvarez-Hernández; Jutta Passlick-Deetjen; Adrian Guinsburg; Cristina Marelli; Diego Rodriguez-Puyol; Jorge B Cannata-Andía
Journal:  Kidney Int       Date:  2008-07-16       Impact factor: 10.612

Review 3.  Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?

Authors:  James B Wetmore; L Darryl Quarles
Journal:  Nat Clin Pract Nephrol       Date:  2008-10-28

Review 4.  Vitamin D receptor: mechanisms for vitamin D resistance in renal failure.

Authors:  Adriana S Dusso
Journal:  Kidney Int Suppl       Date:  2003-06       Impact factor: 10.545

5.  Relationship of calcification of atherosclerotic plaque and arterial stiffness to bone mineral density and osteoprotegerin in postmenopausal women referred for osteoporosis screening.

Authors:  Michelle L Frost; Rodolpho Grella; Sandrine C Millasseau; Ben-Yu Jiang; Geeta Hampson; Ignac Fogelman; Phil J Chowienczyk
Journal:  Calcif Tissue Int       Date:  2008-07-09       Impact factor: 4.333

6.  Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro.

Authors:  H Skjødt; J A Gallagher; J N Beresford; M Couch; J W Poser; R G Russell
Journal:  J Endocrinol       Date:  1985-06       Impact factor: 4.286

7.  Prevention of rickets and vitamin D deficiency in infants, children, and adolescents.

Authors:  Carol L Wagner; Frank R Greer
Journal:  Pediatrics       Date:  2008-11       Impact factor: 7.124

8.  Decreased free 1,25-dihydroxycholecalciferol index in patients with the nephrotic syndrome.

Authors:  J Auwerx; L De Keyser; R Bouillon; P De Moor
Journal:  Nephron       Date:  1986       Impact factor: 2.847

9.  Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.

Authors:  J C Chan; M B Kodroff; D M Landwehr
Journal:  Pediatrics       Date:  1981-10       Impact factor: 7.124

10.  Reduced plasma concentration of 1,25-dihydroxyvitamin D in children with moderate renal insufficiency.

Authors:  A A Portale; B E Booth; H C Tsai; R C Morris
Journal:  Kidney Int       Date:  1982-04       Impact factor: 10.612

View more
  20 in total

Review 1.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

2.  Intracranial calcification in a uremic infant with Wilms' tumor in a solitary kidney.

Authors:  Hiro Matsukura; Keijiro Ibuki; Keiko Nomura; Hiroyuki Higashiyama; Asami Takasaki; Toshio Miyawaki; Atsushi Aikawa; Hirokazu Kanegane
Journal:  CEN Case Rep       Date:  2012-06-08

Review 3.  Arterial calcification and bone physiology: role of the bone-vascular axis.

Authors:  Bithika Thompson; Dwight A Towler
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

4.  How much vitamin D do we need for skeletal health?

Authors:  Christoph von Domarus; Jonathan Brown; Florian Barvencik; Michael Amling; Pia Pogoda
Journal:  Clin Orthop Relat Res       Date:  2011-11       Impact factor: 4.176

5.  Effect of dietary vitamin D and calcium on the growth of androgen-insensitive human prostate tumor in a murine model.

Authors:  Rahul Ray; Mara Banks; Hilal Abuzahra; Vikram J Eddy; Kelly S Persons; M Scott Lucia; James R Lambert; Michael F Holick
Journal:  Anticancer Res       Date:  2012-03       Impact factor: 2.480

Review 6.  Vitamin D and inflammation.

Authors:  Uwe Querfeld
Journal:  Pediatr Nephrol       Date:  2012-12-13       Impact factor: 3.714

7.  Oral active vitamin d treatment and mortality in maintenance hemodialysis patients.

Authors:  Shukun Wu; Junru Wang; Fang Wang; Li Wang
Journal:  Cardiorenal Med       Date:  2014-10-22       Impact factor: 2.041

8.  Effect of DOTS Treatment on Vitamin D Levels in Pulmonary Tuberculosis.

Authors:  Akshatha Lalesh Naik; Madan Gopal Rajan; Poornima A Manjrekar; Mamatha T Shenoy; Souparnika Shreelata; Rukmini Mysore Srikantiah; Anupama Hegde
Journal:  J Clin Diagn Res       Date:  2017-04-01

Review 9.  Neurologic Complications of Chronic Kidney Disease.

Authors:  Kavitha Vellanki; Vinod K Bansal
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 5.081

Review 10.  The effect of vitamin D status on risk factors for cardiovascular disease.

Authors:  Sujana S Gunta; Ravi I Thadhani; Robert H Mak
Journal:  Nat Rev Nephrol       Date:  2013-04-23       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.